Johnson & Johnson (JNJ) Other Non Operating Income (2009 - 2026)

Johnson & Johnson has reported Other Non Operating Income for 18 years, with the latest figure at -$331.0 million in Q2 2026.

• Quarterly Other Non Operating Income fell 209.35% year-over-year to -$331.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$630.0 million (down 111.3% YoY) and the FY2025 annual result came in at $7.2 billion, up 253.58% from the prior year.
• Other Non Operating Income eased to -$331.0 million in Q2 2026 per JNJ's latest filing, from -$294.0 million in the prior quarter.
• Over five years, Other Non Operating Income peaked at $7.3 billion in Q1 2025 and troughed at -$6.9 billion in Q2 2023.
• A 5-year average of -$303.9 million and a median of -$283.5 million in 2022 frame the typical range for Other Non Operating Income.
• The sharpest annual moves came in 2023 and 2025: Other Non Operating Income sank 6903.92% in 2023, then jumped 404.53% in 2025.
• Over 5 years, Other Non Operating Income stood at -$226.0 million in 2022, then jumped by 286.28% to $421.0 million in 2023, then plunged by 61.76% to $161.0 million in 2024, then plunged by 400.0% to -$483.0 million in 2025, then surged by 31.47% to -$331.0 million in 2026.
• According to Business Quant data, Other Non Operating Income over the past three periods registered -$331.0 million, -$294.0 million, and -$483.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.